You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
The role of molecular genetics in the treatment of malignancy continues to grow at an astonishing rate. Today’s subspecialized multidisciplinary approach to oncology has incorporated advances in targeted molecular therapy, prognosis, risk assessment, and prevention—all based at least in part on molecular diagnostics and imaging. Inside this cutting-edge resource, readers will explore broad, comprehensive perspectives on the current trends in molecular diagnosis of cancer and personalized cancer medicine. Authoritative discussions share insights from noted experts in cancer research, clinical trials, molecular diagnostics, personalized therapy, bioinformatics, and federal regulations. From the basic mechanisms of carcinogenesis to the most advanced molecular screening, staging, and treatment technologies, readers will discover clear and straightforward discussions directly relevant to patient diagnosis and care.
Chronic hepatitis B (CHB) is a life-threatening liver disease affecting 257 million people worldwide, in particular in the Asia-Pacific regions. In endemic areas, hepatitis B virus (HBV) is usually transmitted from chronically infected mothers to neonates. Perinatal HBV infection causes chronic infection in more than 90% of exposed individuals. With perinatal infection, lifetime mortality risk due to complications of liver cirrhosis (LC) or hepatocellular carcinoma (HCC) reaches up to 40% in men and 15% in women. For the treatment of chronic HBV infection, nucleos(t)ide analogue antivirals have been successfully used to suppress viral replication. However, HBV exists as a cccDNA, which canno...
Historically the study of the immune system and metabolism have been two very separate fields. In recent years, a growing literature has emerged illustrating how the multiple processes of cellular metabolism are intricately linked to several aspects of immune function and development. This Research Topic covers recent progress in the field now known as “Immunometabolism” and the role of metabolism in immune tolerance. Immune tolerance is operationally defined as a state where a host’s immune system is balanced such that although self-reactive lymphocytes are present, they are kept in check by immune regulation. Perturbations to this homeostasis may result in self-reactive lymphocytes g...
Recently, a friend of mine lost her sight. The reason, diabetes. I immediately called for an appointment. After the usual battery of tests, the ophthalmologist declared with a smile "you have the eyes of a 20 year-old". At 59, my eyes are as good as nearly 40 years ago! So, how to keep healthy eyes? Naturally, on top of the list, UV protection glasses, but the big surprise was to learn the importance of eating a variety of vegetables and fruits. With a degree in Biochemistry and a Ph.D in Medical Information, I have some knowledge of physiology and metabolism. However, I needed to learn more about nutrition, and decided to read the latest scientific studies, and I discovered surprising facts...
October is the Liver Cancer Awareness Month and at Frontiers in Oncology we want to highlight the recent discoveries in the field and raise awareness of the importance of early diagnosis, multidisciplinary management, and technological innovation support. Primary liver cancer represents a significant global health challenge, with its incidence steadily rising and posing substantial morbidity and mortality rates. This research topic in Frontiers in Oncology focuses on the latest advancements in the investigation and treatment of primary liver cancer, addressing hepatocellular carcinoma (HCC) and cholangiocarcinoma to provide insights into cutting-edge approaches to shaping the field and improving patient outcomes
Hepatocellular carcinoma (HCC) is the most common cancer of the liver and the third most cause of cancer-related deaths worldwide. The 5-year survival of HCC is less than 20%, making HCC the second most lethal malignancy; the first being pancreatic cancer. HCC usually occurs in patients with chronic liver disease in association with a variety of risk factors, including chronic liver infection with hepatitis B virus or hepatitis C virus; excessive consumption of alcohol; overeating, obesity, and nonalcoholic fatty liver disease; other metabolic liver diseases including Wilson’s disease, hemochromatosis, and alpha-1-antitrypsin deficiency; and environmental toxins such as aflatoxins. Tobacco...